Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It consists of the 44-amino acid GHRH sequence with an added trans-3-hexenoic acid group, enhancing stability and receptor binding.

How does Tesamorelin differ from CJC-1295?

While both target GHRH receptors, Tesamorelin is a full-length GHRH analog with enhanced stability, whereas CJC-1295 is a modified fragment (amino acids 1-29) with Drug Affinity Complex modifications.

What research applications?

Tesamorelin is studied in preclinical models for its effects on the GH/IGF-1 axis, lipid metabolism, and body composition regulation through GHRH receptor activation.

What purity is your Tesamorelin?

Our Tesamorelin is verified at ≥99% purity via third-party HPLC analysis. A Certificate of Analysis is included with every order.

Growth Hormone

Tesamorelin (GHRH Analog)

Name: Tesamorelin (GHRH Analog)
Brand: ANVIL PEPTIDES
SKU: tesamorelin
Availability: InStock
Rating: 4.9 (47 reviews)

≥99% (HPLC Verified) PurityLyophilized Powder

Stabilized GHRH analog — pulsatile GH release and body composition research

Select Size

$89.99$119.99-25%

LAUNCH35Extra 35% off → $58.49

1

Most researchers order 2+ vials per protocol

3rd Party TestedCOA Every BatchFree US ShippingSecure Checkout

For research use only. Not for human consumption.

Overview

Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH) consisting of the full 44-amino acid GHRH(1-44) sequence with an N-terminal trans-3-hexenoic acid modification conferring enhanced enzymatic stability. It binds the GHRH receptor on pituitary somatotrophs, stimulating adenylyl cyclase activity and cAMP-mediated GH gene transcription. Tesamorelin preserves physiological GH pulsatility and is studied for its effects on growth hormone dynamics, lipid metabolism, and body composition parameters in preclinical models.

Specifications

Form	Lyophilized Powder
Purity	≥99% (HPLC Verified)
Storage	-20°C (Freeze Dried)
Molecular Weight	5135.89 g/mol

Frequently Asked Questions

Tesamorelin is a synthetic analog of human GHRH consisting of the full 44-amino acid GHRH(1-44) sequence with an N-terminal trans-3-hexenoic acid modification for enhanced enzymatic stability. It binds the GHRH receptor on pituitary somatotrophs, stimulating cAMP-mediated GH gene transcription.

Both are GHRH receptor agonists, but Tesamorelin is based on the full-length 44-amino acid GHRH sequence, while CJC-1295 (Mod GRF 1-29) uses only the first 29 amino acids with four substitutions for DPP-IV resistance. Tesamorelin preserves more of the native GHRH structure and signaling profile.

Tesamorelin is studied for its effects on physiological GH pulsatility, lipid metabolism parameters, and body composition changes in preclinical models. Its ability to stimulate GH release while preserving natural pulsatile patterns makes it valuable for GH-axis pharmacology research.

Tesamorelin is verified at ≥99% purity via HPLC analysis. Store at -20°C. COA with full analytical data included with every order.